Heart Arrhythmia: Digital Silver Lining Seen in Failed COVID-19 Drug Trial
Photo: UW Medicine
A clinical trial in which two test drugs failed to help patients with mild COVID-19 nevertheless had a silver lining: It proved the viability of a study model in which a medication’s potential arrhythmic side effects are safely, effectively monitored without the participants ever setting foot in a hospital or clinic.
The findings are reported Dec. 20, 2021, in the journal Communications Medicine. They also suggest that remote studies can expand clinical research to broader populations and greatly reduce participants’ burdens of time, travel and cost, said Dr. Arun Sridhar, a senior author.